Skip to main navigationSkip to main content
The University of Southampton
Southampton Clinical Trials UnitNews

Immune-boosting antibody combination could improve lymphoma survival (RiVa Study)

Published: 4 December 2017

Combining two different immunotherapy treatments could dramatically improve lymphoma survival, according to a Cancer Research UK funded study published in Cancer Cell

See full news release here

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.